Insider Trading History of De Rubertis Francesco

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of De Rubertis Francesco since 2014. This trader's CIK number is 1601521. At the time of last reporting, De Rubertis Francesco was the Director of Centessa Pharmaceuticals Plc. (stock ticker symbol CNTA). Also see all insider trading activities at Centessa Pharmaceuticals Plc.

Note that in the past De Rubertis Francesco also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Minerva Neurosciences, Inc. (NERV) by De Rubertis Francesco

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 NERV 0 $0 1,000,000 $10,000,000 0 $0
2015 NERV 202,634 $974,669 0 $0 0 $0
2014 NERV 1,620,833 $9,724,998 0 $0 0 $0

Yearly summary of insider trading at Centessa Pharmaceuticals Plc (CNTA) by De Rubertis Francesco

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 CNTA 200,000 $2,426,662 0 $0 0 $0


Insider trading activities at 2 companies by De Rubertis Francesco:

1. Minerva Neurosciences, Inc. (NERV)

2. Centessa Pharmaceuticals Plc (CNTA)

Table 1. Insider trading of Minerva Neurosciences, Inc. (NERV) by De Rubertis Francesco

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-08-10 NERV Sale 1,000,000 10.00 10,000,000
2015-03-18 NERV Buy 202,634 4.81 974,669
2014-07-07 NERV Buy 1,620,833 6.00 9,724,998

Table 2. Insider trading of Centessa Pharmaceuticals Plc (CNTA) by De Rubertis Francesco

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-12-02 CNTA Buy 34,326 12.82 440,059
2021-11-30 CNTA Buy 36,847 11.62 428,162
2021-12-01 CNTA Buy 60,304 12.62 761,036
2021-11-29 CNTA Buy 56,706 11.70 663,460
2021-11-26 CNTA Buy 11,817 11.34 133,945

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by De Rubertis Francesco (Director of Centessa Pharmaceuticals Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.